Perioperative anemia and blood transfusions as prognostic factors in patients undergoing resection for non-small cell lung cancers

Lung Cancer

Volumn 49, Issue 3, 2005, Pages 371-376

  Berardi, R ^a   Brunelli, A ^a   Tamburrano, T ^a   Verdecchia, L ^a   Onofri, A ^a   Zuccatosta, L ^b   Gasparini, S ^b   Santinelli, A ^a   Scartozzi, M ^a   Valeri, G ^a   Giovagnoni, A ^a   Giuseppetti, G M ^a   Fabris, G ^a   Marmorale, C ^a   Fianchini, A ^a   Cascinu, S ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b OSPEDALI RIUNITI   (Italy)

Author keywords

Anemia; Blood transfusions; Non small cell lung cancer; Prognostic factors

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; RISK REDUCTION; SAMPLE SIZE; SURGICAL WARD; THORAX SURGERY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD TRANSFUSION; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 23744444690     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2005.04.011     Document Type: Article

References (33)

1. D.E. Van Raemdonck, A. Schneider, and R.J. Ginsberg Surgical treatment for higher stage non-small cell lung carcinoma Ann Thorac Surg 54 1992 999 1013
2. M.H. Gail, R.T. Eagan, R. Field, R. Ginsberg, B. Goodell, L. Hill Prognostic factors in patients with resected stage I non-small cell lung cancer A report from the Lung Cancer Study Group Cancer 54 1984 1802 1813
3. L.B. Harrison, M. Chadha, R.J. Hill, K. Hu, and D. Shasha Impact of tumor hypoxia and anemia on radiation therapy outcomes Oncologist 7 2002 492 508
4. C. Ohlhauser, H. Bulzebruck, and W. Ebert Prognostic factors for survival in inoperable non-small-cell lung cancer: a multivariate regression analysis of 456 patients with radiation therapy Onkologie 20 1997 126 131
5. S. Ylisirnio, M.L. Sassi, J. Risteli, T. Turpeeniemi-Hujanen, and A. Jukkola Serum type I collagen degradation markers, ICTP and CrossLaps, are factors for poor survival in lung cancer Anticancer Res 19 1999 5577 5581
6. O. Pradier, K. Lederer, A. Hille, E. Weiss, H. Christiansen, and H. Schmidberger Concurrent low-dose cisplatin and thoracic radiotherapy in patients with inoperable stage III non-small cell lung cancer: a phase II trial with special reference to the hemoglobin level as prognostic parameter J Cancer Res Clin Oncol 2004
7. D.A. Fein, W.R. Lee, Hanlon Al, J.A. Ridge, C.J. Langer, and W.J. Curran Jr Pretreatment hemoglobin levels influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx J Clin Oncol 13 1995 2077 2083
8. C. Manegold The causes and prognostic significance of low haemoglobin levels in tumor patients Strahlenther Onk 174 1998 17 19
9. P.J. Barret-Lee, N.P. Bailey, M.E.R. O' Brien, E. Wager, and U.K. Largescale Audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy Br J Cancer 82 2000 93 97
10. L. Burrows, and P. Tartter Effect of blood transfusions on colonic malignancy recurrence rate Lancet 2 1982 662
11. M. Nowak, and J. Ponsky Blood transfusion and disease-free survival in carcinoma of the breast J Surg Oncol 27 1984 124 130
12. R.S. Foster, M.C. Costanza, J.C. Foster, M.C. Wanner, and C.B. Foster Adverse relationship between blood transfusions and survival after colectomy for colon cancer Cancer 55 1985 1195 1201
13. S.A. Rosenberg, C.A. Seipp, D.E. White, and R. Wesley Perioperative blood transfusions are associated with increased rates of recurrence and decreased survival in patients with high-grade soft-tissue sarcomas of the extremities J Clin Oncol 3 1985 698 709
14. P.I. Tartter, L. Burrows, and P. Kirschner Perioperative blood transfusion adversely affects prognosis after resection of stage I (subset NO) non-oat cell lung cancer J Thorac Cardiovasc Surg 88 1984 659 662
15. N.H. Hyman, R.S. Foster Jr, J.E. De Meules, and M.C. Costanza Blood transfusions and survival after lung cancer resection Am J Surg 149 1985 502 507
16. J. Corman, R. Arnoux, A. Peloquin, G. St Louis, and C. Smeester Perioperative blood transfusions and colorectal cancer outcome Transplant Proc 20 1998 1128 1129
17. R. MacRae, Y. Shyr, D. Johnson, and H. Choy Declining hemoglobin during chemoradiotherapy for locally advanced non-small cell lung cancer is significant Radiother Oncol 64 2002 37
18. M. Nosotti, P. Rebulla, D. Riccardi, A. Baisi, N. Bellaviti, and L. Rosso Correlation between perioperative blood transfusion and prognosis of patients surgery for stage I lung cancer Chest 124 2003 102 107
19. S. Piantadosi, D.W.O. Moores, and M.F. McKneally The adverse effect of perioperative blood transfusion in lung cancer Chest 106 1994 382 384
20. T.J. Robnett, M. Machtay, S.M. Hahn, J.B. Shrager, J.S. Friedberg, and L.R. Kaiser Pathological response to preoperative chemoradiation worsens with anemia in non-small cell lung cancer patients Cancer J 8 2002 263 267
21. M.A. Blajchman Allogeneic blood transfusion, immunomodulation and postoperative bacterial infection: do we have the answers yet? Transfusion 37 1997 121 125
22. G. Opelz, B. Graver, and P.I. Terasaki Induction of high kidney graft survival rate by multiple transfusion Lancet 1 1981 1223 1225
23. M.D. Smith, J.D. Williams, G.A. Coles, and J.R. Salaman The effect of blood transfusion on T-suppressor cells in renal dialysis patients Transplant Proc 13 1981 181 183
24. S. Sanfilippo, W.K. Vaughn, R.R. Bollinger, and E.K. Spees The influence of pretransplant transfusions, using different products on patients sensitization and renal allograft survival Transplantation 37 1984 350 356
25. D.R. Cox Regression models and life-tables J R Stat Soc 34 1972 187 220
26. K.S. Albain, J.J. Crowley, M. LeBlanc, and R.B. Livingston Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience J Clin Oncol 1991 618 1626
27. M.J. Van Acht, J. Hermans, D.E. Boks, and J.W. Leer The prognostic value of hemoglobin and a decrease in hemoglobin during radiotherapy in laringeal carcinoma Radiother Oncol 23 1992 229 235
28. M. Grogan, G.M. Thomas, I. Melamed, F.L. Wong, R.G. Pearcey, and P.K. Joseph The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix Cancer 86 1999 1528 1536
29. J.S. Waters, M.E. O'Brien, and S. Ashley Management of anemia in patients receiving chemotherapy J Clin Oncol 20 2002 601 603
30. D.K. Kelleher, U. Mattheinsen, O. Thews, and P. Vaupel Blood flow, oxygenation, and bioenergetic status of tumors after erythropoietin treatment in normal and anemic rats Cancer Res 56 1996 4278 4334
31. J.H. Dunst, A. Feldman, and A. Becker Oxygenation of human tumors: the Munich/Halle experience P. Vaupel D. Kelleher Tumor hypoxia: pathology, clinical significance and therapeutic perspectives 1999 Wissenschaftliche Vertagsgesellschaft Stuttgart, Germany 39 41
32. A. Becker, P. Stadler, R.S. Lavey, G. Hansgen, T. Kuhnt, and C. Lautenschlager Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas Int J Radiat Oncol Biol Phys 46 2000 459 466
33. G.L. Semenza HIF-1 and tumor progression: pathophysiology and therapeutics Trends Mol Med 8 2002 S62 S67